Table 1.

Outcomes of the 12 studies used.

No.	Study	Citation	Arm	Serum Creatinine		Proteinuria
No.	Study	Citation	Arm	Response	Arm Size	Response	Arm Size
1	Appel, 2009	18	CYC	125	185	50	185
1	Appel, 2009	18	MMF	130	185	44	185
2	Chan, 2005	19	CYC			23	31
2	Chan, 2005	19	MMF			24	33
3	Chen, 2011	20	CYC	33	39	15	39
3	Chen, 2011	20	Tac	38	42	22	42
4	Donadio, 1972	21	AZA			2	7
4	Donadio, 1972	21	Prednisone alone			2	9
5	Donadio, 1976	17	CYC			4	19
5	Donadio, 1976	17	Prednisone alone			2	20
6	El-Shafey, 2010	22	CYC	5	23	5	23
6	El-Shafey, 2010	22	MMF	6	24	6	24
7	Ginzler, 2005	23	CYC	4	69	4	69
7	Ginzler, 2005	23	MMF	16	71	16	71
8	Hahn, 1975	24	AZA			8	11
8	Hahn, 1975	24	Prednisone alone			8	10
9	Li, 2012	9	CYC			6	20
			MMF			9	20
			Tac			9	20
10	Miyasaka, 2009	25	Tac			4	27
10	Miyasaka, 2009	25	Prednisone alone			1	33
11	Ong, 2005	26	CYC			3	25
11	Ong, 2005	26	MMF			5	19
12	Ren, 2007	27	CYC	3	12	3	12
12	Ren, 2007	27	Tac	6	13	6	13

The outcome used is the number of renal remissions, as defined by serum creatinine < 132 µmol/l; proteinuria < 0.5 g/day. Response: no. responses in each arm; arm size: sample size of each arm; MMF: mycophenolate mofetil; CYC: cyclophosphamide; Tac: tacrolimus; AZA: azathioprine.